A quantitative in vivo CRISPR-imaging platform identifies regulators of hyperplastic and hypertrophic adipose morphology in zebrafish
eLife · 22.04.2026 · 14
DOI: 10.7554/elife.107327 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 22.04.2026. Verfasst von Rebecca Wafer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Neuroscience and Cardiovascular Research, Edinburgh BioQuarter, College of Medicine and Veterinary Medicine, University of Edinburgh, E…. Hauptthemen laut MEDLINE: Zebrafish, Adipose Tissue, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, British Heart Foundation.
Abstract (Originalsprache)
Adipose tissues exhibit a remarkable capacity to expand, regress, and remodel in response to energy status. The cellular mechanisms underlying adipose remodelling are central to metabolic health. Hypertrophic remodelling – characterised by the enlargement of existing adipocytes – is associated with insulin resistance, type 2 diabetes, and cardiovascular disease. In contrast, hyperplastic remodelling – in which new adipocytes are generated – is linked to improved metabolic outcomes. Despite its clinical importance, the regulation of hypertrophic and hyperplastic adipose morphology remains poorly understood. Here, we integrate human transcriptomic data with a quantitative CRISPR-imaging platform in zebrafish to identify regulators of adipose morphology. We developed an image-based phenotyping pipeline that captures lipid droplet size, number, and spatial patterning, and applied generalised additive modelling to quantify hyperplastic versus hypertrophic morphology signatures. Using this platform, we conducted an F0 CRISPR screen targeting 25 candidate genes and identified three that induced hypertrophic morphology ( txnipa , mmp14b, and foxp1b ) and an additional candidate that altered total adiposity ( kazna ). For functional validation, we generated stable loss-of-function alleles for both zebrafish foxp1 paralogues. Spatial analysis along the anterior-posterior axis revealed that foxp1b mutants display developmental hypertrophy but profoundly blunted adaptive responses to high-fat diet (~68% reduction across all spatial zones), while foxp1a mutants show normal baseline morphology but disrupted spatial patterning of diet-induced hypertrophy. Together, these findings establish a scalable CRISPR-imaging platform for in vivo genetic screening of adipose morphology and reveal distinct roles for Foxp1 paralogues in developmental patterning and adaptive responses to dietary challenge in adipose tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Neuroscience and Cardiovascular Research, Edinburgh BioQuarter, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
ORCID-Profile: Rebecca Wafer, James Minchin
Förderung
- Biotechnology and Biological Sciences Research Council
- British Heart Foundation
Zitieren
APA
Wafer, R., Tandon, P., & Minchin, J. (2026). A quantitative in vivo CRISPR-imaging platform identifies regulators of hyperplastic and hypertrophic adipose morphology in zebrafish. eLife, 14. https://doi.org/10.7554/elife.107327
Vancouver
Wafer R, Tandon P, Minchin J. A quantitative in vivo CRISPR-imaging platform identifies regulators of hyperplastic and hypertrophic adipose morphology in zebrafish. eLife. 2026;14. doi:10.7554/elife.107327
BibTeX
@article{Wafer2026,
author = {Wafer, Rebecca and Tandon, Panna and Minchin, James},
title = {A quantitative in vivo CRISPR-imaging platform identifies regulators of hyperplastic and hypertrophic adipose morphology in zebrafish},
journal = {eLife},
year = {2026},
volume = {14},
doi = {10.7554/elife.107327}
}
EUVIMED